Pan, Xiaoxi;
AbdulJabbar, Khalid;
Coelho-Lima, Jose;
Grapa, Anca-Ioana;
Zhang, Hanyun;
Cheung, Alvin Ho Kwan;
Baena, Juvenal;
... Moore, David A; + view all
(2024)
The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma.
Nature Cancer
10.1038/s43018-023-00694-w.
Preview |
PDF
s43018-023-00694-w.pdf - Published Version Download (11MB) | Preview |
Abstract
The introduction of the International Association for the Study of Lung Cancer grading system has furthered interest in histopathological grading for risk stratification in lung adenocarcinoma. Complex morphology and high intratumoral heterogeneity present challenges to pathologists, prompting the development of artificial intelligence (AI) methods. Here we developed ANORAK (pyrAmid pooliNg crOss stReam Attention networK), encoding multiresolution inputs with an attention mechanism, to delineate growth patterns from hematoxylin and eosin-stained slides. In 1,372 lung adenocarcinomas across four independent cohorts, AI-based grading was prognostic of disease-free survival, and further assisted pathologists by consistently improving prognostication in stage I tumors. Tumors with discrepant patterns between AI and pathologists had notably higher intratumoral heterogeneity. Furthermore, ANORAK facilitates the morphological and spatial assessment of the acinar pattern, capturing acinus variations with pattern transition. Collectively, our AI method enabled the precision quantification and morphology investigation of growth patterns, reflecting intratumoral histological transitions in lung adenocarcinoma.
Type: | Article |
---|---|
Title: | The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1038/s43018-023-00694-w |
Publisher version: | http://dx.doi.org/10.1038/s43018-023-00694-w |
Language: | English |
Additional information: | This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third-party material in this article are included in the Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
Keywords: | TRACERx Consortium |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > CRUK Cancer Trials Centre UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology |
URI: | https://discovery.ucl.ac.uk/id/eprint/10185748 |
Archive Staff Only
![]() |
View Item |